pI: 6.4881 |
Length (AA): 184 |
MW (Da): 20820 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 3 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
2 | 176 | 1fzq (A) | 2 | 177 | 52.00 | 0 | 1 | 1.72139 | -1.59 |
2 | 184 | 3doe (A) | 2 | 184 | 71.00 | 0 | 1 | 1.92587 | -1.3 |
18 | 179 | 5de3 (A) | 18 | 179 | 53.00 | 0 | 1 | 1.64383 | -1.55 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_128319)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT2G18390 | ADP-ribosylation factor-like protein 2 |
Babesia bovis | BBOV_I002140 | ADP-ribosylation factor-like protein 2, putative |
Brugia malayi | Bm1_08620 | ADP-ribosylation factor-like protein 2 |
Candida albicans | CaO19.10442 | potential ARF-like GTP-binding protein similar to S. cerevisiae CIN4 (YMR138W) involved in beta tubulin folding |
Candida albicans | CaO19.2925 | potential ARF-like GTP-binding protein similar to S. cerevisiae CIN4 (YMR138W) involved in beta tubulin folding |
Caenorhabditis elegans | CELE_F22B5.1 | Protein EVL-20 |
Cryptosporidium hominis | Chro.10030 | ADP-ribosylation factor-like protein 2 (ARL2) |
Cryptosporidium parvum | cgd1_200 | ADP-ribosylation factor-like protein 2 (ARL2), putative |
Dictyostelium discoideum | DDB_G0281307 | ADP-ribosylation factor-like protein |
Drosophila melanogaster | Dmel_CG7435 | ADP ribosylation factor-like 2 |
Echinococcus granulosus | EgrG_000459100 | ADP ribosylation factor 2 |
Echinococcus multilocularis | EmuJ_000459100 | ADP ribosylation factor 2 |
Giardia lamblia | GL50803_4192 | ARL2 |
Homo sapiens | ENSG00000213465 | ADP-ribosylation factor-like 2 |
Leishmania braziliensis | LbrM.34.0170 | ADP-ribosylation factor-like 2, arl2, putative |
Leishmania donovani | LdBPK_350130.1 | ADP-ribosylation factor, putative |
Leishmania infantum | LinJ.35.0130 | ADP-ribosylation factor-like 2, arl2, putative |
Leishmania major | LmjF.35.0130 | ADP-ribosylation factor-like 2, arl2, putative |
Leishmania mexicana | LmxM.34.0130 | ADP-ribosylation factor, putative |
Mus musculus | 56327 | ADP-ribosylation factor-like 2 |
Neospora caninum | NCLIV_013060 | ADP-ribosylation factor domain-containing protein, putative |
Oryza sativa | 4329193 | Os02g0327100 |
Onchocerca volvulus | OVOC13476 |
|
Plasmodium berghei | PBANKA_1305900 | ADP-ribosylation factor, putative |
Plasmodium falciparum | PF3D7_1442000 | ADP-ribosylation factor, putative |
Plasmodium knowlesi | PKNH_1240300 | ADP-ribosylation factor, putative |
Plasmodium vivax | PVX_118390 | ADP-ribosylation-like factor, putative |
Plasmodium yoelii | PY00881 | probable adp-ribosylation factor at2g18390 |
Saccharomyces cerevisiae | YMR138W | Arf family GTPase CIN4 |
Schistosoma japonicum | Sjp_0072160 | ko:K07943 ADP-ribosylation factor-like 2, putative |
Schistosoma mansoni | Smp_164660 | ADP-ribosylation factor-like 2 arl2 |
Schmidtea mediterranea | mk4.001892.00 | ADP-ribosylation factor-like protein 2 |
Schmidtea mediterranea | mk4.046268.00 | |
Trypanosoma brucei gambiense | Tbg972.10.5270 | ADP-ribosylation factor, putative |
Trypanosoma brucei | Tb927.10.4250 | ADP-ribosylation factor-like 2, arl2 |
Trypanosoma cruzi | TcCLB.506295.80 | ADP-ribosylation factor-like 2, arl2, putative |
Trypanosoma cruzi | TcCLB.511469.24 | ADP-ribosylation factor-like 2, arl2, putative |
Toxoplasma gondii | TGME49_212950 | ADP-ribosylation factor family protein 2, putative |
Theileria parva | TP03_0117 | ADP-ribosylation factor, putative |
Theileria parva | TP03_0116 | hypothetical protein |
Trichomonas vaginalis | TVAG_262220 | ADP-ribosylation factor, arf, putative |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.10.4250 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.10.4250 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.10.4250 | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb927.10.4250 | Trypanosoma brucei | significant gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
CELE_F22B5.1 | Caenorhabditis elegans | embryonic lethal | wormbase |
CELE_F22B5.1 | Caenorhabditis elegans | slow growth | wormbase |
TGME49_212950 | Toxoplasma gondii | Probably essential | sidik |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.